| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4204921 | Archivos de Bronconeumología | 2006 | 4 Pages |
Abstract
Intravenous administration of magnesium sulfate has no bronchodilating effect in patients with COPD exacerbations. It does, however, enhance the bronchodilating effect of inhaled β2-agonists.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Juan Abreu González, Concepción Hernández GarcÃa, Pedro Abreu González, Candelaria MartÃn GarcÃa, Alejandro Jiménez,